You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Psoriasis Forum

  • Authors: Linda F. Stein Gold, MD; Kenneth B. Gordon, MD; Jennifer Soung, MD; Bruce E. Strober, MD, PhD
  • CME / ABIM MOC / CE Released: 11/29/2022
  • Valid for credit through: 11/29/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.50 ABIM MOC points

    Nurses - 1.50 ANCC Contact Hour(s) (1.25 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for dermatologists, rheumatologists, primary care physicians, pediatricians, nurses, nurse practitioners, and physician assistants involved in the care of patients with psoriasis.

The goal of this activity is for the learner to be better able to manage and treat psoriasis in various patient populations.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Integration of new topical psoriasis treatments in care plans across the severity spectrum
    • Clinical evidence regarding biologic psoriasis treatments
    • Updates on clinical data for targeted oral psoriasis therapies
    • Treatment strategies for individualized management of psoriasis


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Chair

  • Linda F. Stein Gold, MD

    Director of Dermatology Research
    Division Head of Dermatology
    Henry Ford Health System
    Detroit, Michigan

    Disclosures

    Linda F. Stein Gold, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Amgen; Arcutis; Bristol Myers Squibb; Dermavant; EPI Health; Galderma; Janssen; Incyte; Ortho Dermatologics; Pfizer; Regeneron; Sanofi; UCB
    Speaker or member of speakers bureau for: Amgen; AbbVie; Incyte; Pfizer; Regeneron; Sanofi; Sun
    Research funding from: AbbVie; Amgen; Arcutis; Dermata; Dermavant; Galderma; Incyte; Ortho Dermatologics; Pfizer; UCB

Speakers

  • Kenneth B. Gordon, MD

    Professor and Chair of Dermatology
    Medical College of Wisconsin
    Milwaukee, Wisconsin

    Disclosures

    Kenneth B. Gordon, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Almirall; Amgen; Arcutis; Arena; Bristol Myers Squibb Company; Dermavant; Incyte; Janssen; Kyowa Kirin; Leo Pharma; Lilly; MoonLake; Ortho Dermatologics; Pfizer; Regeneron; Sanofi; Sun; UCB
    Research funding from: AbbVie; Bristol Myers Squibb Company; Lilly; UCB

  • Jennifer Soung, MD

    Clinical Faculty of Dermatology
    Southern California Dermatology
    Director of Clinical Research
    Harbor-UCLA Medical Center
    Santa Ana, California

    Disclosures

    Jennifer Soung, MD, has the following relevant financial relationships:
    Consultant or advisor for: Arcutis; Bristol Myers Squibb Company; Dermavant; Novartis
    Speaker or member of speakers bureau for: AbbVie; Amgen; Arcutis; Bristol Myers Squibb Company; Celgene; Leo Pharma; Lilly; Novartis; Ortho Dermatologics; Pfizer; Regeneron; Sanofi
    Research funding from: AbbVie; Amgen; Arcutis; Castle Biosciences; Dermavant; KoBio; Kyowa Kirin; Leo Pharma; Lilly; Novartis; Pfizer; UCB

  • Bruce E. Strober, MD, PhD

    Clinical Professor
    Yale University and Central Connecticut Dermatology
    Cromwell, Connecticut

    Disclosures

    Bruce E. Strober, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Almirall; Amgen; Arcutis; Arena; Aristea; Asana; Boehringer Ingelheim; Bristol Myers Squibb Company; Connect Biopharma; Dermavant; EPI Health; Evelo Biosciences; Immunic Therapeutics; Janssen; Leo Pharma; Lilly; Maruho; Meiji; Mindera Health; Novartis; Ono; Pfizer; Regeneron; Sanofi Genzyme; Seika; Sun; UCB; Union Therapeutics; Ventyxbio; vTv
    Speaker or member of speakers bureau for: AbbVie; Incyte; Janssen; Lilly; Regeneron; Sanofi Genzyme
    Research funding from: AbbVie; Cara; Dermavant; Dermira; Novartis
    Stock options from: Connect; Mindera Health

Editor

  • Karen Badal, MD, MPH

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Karen Badal, MD, MPH, has no relevant financial relationships.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.25 contact hours are in the area of pharmacology. 

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Psoriasis Forum

Authors: Linda F. Stein Gold, MD; Kenneth B. Gordon, MD; Jennifer Soung, MD; Bruce E. Strober, MD, PhDFaculty and Disclosures

CME / ABIM MOC / CE Released: 11/29/2022

Valid for credit through: 11/29/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Pathophysiology of Psoriasis

Dr Gordon reviews the pathophysiology of psoriasis.
Kenneth B. Gordon, MD

The Topical Psoriasis Treatment Update

Dr Stein Gold discusses the latest in topical treatments for psoriasis.
Linda F. Stein Gold, MD

The New Scene in Targeted Oral Agents

Dr Gordon covers some of the latest data in oral agents for psoriasis.
Kenneth B. Gordon, MD

New Data in Approved Biologics

Dr Strober reviews the most recent data in biologics for the treatment of psoriasis.
Bruce E. Strober, MD, PhD

A Practical Guide to Psoriasis in Hard-to-Treat Areas

Dr Soung reviews the management and treatment of psoriasis in hard to treat areas.
Jennifer Soung, MD

The View of Psoriasis: Practice Pearls

Dr Strober leads the expert panel in a case based discussion.
Bruce E. Strober, MD, PhD and Panel
 

Learning feedback questions

Before you begin, please take this brief survey.

  • Print